DRUG
Price
$52.20
Change
-$0.15 (-0.29%)
Updated
Sep 26, 04:14 PM (EDT)
Capitalization
361.84M
RANI
Price
$0.48
Change
-$0.00 (-0.00%)
Updated
Sep 26, 01:25 PM (EDT)
Capitalization
22.95M
47 days until earnings call
Interact to see
Advertisement

DRUG vs RANI

Header iconDRUG vs RANI Comparison
Open Charts DRUG vs RANIBanner chart's image
Bright Minds Biosciences
Price$52.20
Change-$0.15 (-0.29%)
Volume$100
Capitalization361.84M
Rani Therapeutics Holdings
Price$0.48
Change-$0.00 (-0.00%)
Volume$1.98K
Capitalization22.95M
DRUG vs RANI Comparison Chart in %
Loading...
DRUG
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RANI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
DRUG vs. RANI commentary
Sep 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DRUG is a Buy and RANI is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 26, 2025
Stock price -- (DRUG: $52.35 vs. RANI: $0.48)
Brand notoriety: DRUG and RANI are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DRUG: 148% vs. RANI: 28%
Market capitalization -- DRUG: $361.84M vs. RANI: $22.95M
DRUG [@Biotechnology] is valued at $361.84M. RANI’s [@Biotechnology] market capitalization is $22.95M. The market cap for tickers in the [@Biotechnology] industry ranges from $97.91B to $0. The average market capitalization across the [@Biotechnology] industry is $1.9B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DRUG’s FA Score shows that 0 FA rating(s) are green whileRANI’s FA Score has 0 green FA rating(s).

  • DRUG’s FA Score: 0 green, 5 red.
  • RANI’s FA Score: 0 green, 5 red.
According to our system of comparison, DRUG is a better buy in the long-term than RANI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DRUG’s TA Score shows that 5 TA indicator(s) are bullish while RANI’s TA Score has 5 bullish TA indicator(s).

  • DRUG’s TA Score: 5 bullish, 4 bearish.
  • RANI’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, both DRUG and RANI are a good buy in the short-term.

Price Growth

DRUG (@Biotechnology) experienced а +4.40% price change this week, while RANI (@Biotechnology) price change was -0.50% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.99%. For the same industry, the average monthly price growth was +9.33%, and the average quarterly price growth was +51.85%.

Reported Earning Dates

RANI is expected to report earnings on Nov 12, 2025.

Industries' Descriptions

@Biotechnology (+3.99% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DRUG($362M) has a higher market cap than RANI($23M). DRUG YTD gains are higher at: 45.336 vs. RANI (-65.022). DRUG has higher annual earnings (EBITDA): -8.94M vs. RANI (-47.11M). DRUG has more cash in the bank: 51.4M vs. RANI (10.2M). DRUG has less debt than RANI: DRUG (141K) vs RANI (21.6M). RANI has higher revenues than DRUG: RANI (1.2M) vs DRUG (0).
DRUGRANIDRUG / RANI
Capitalization362M23M1,574%
EBITDA-8.94M-47.11M19%
Gain YTD45.336-65.022-70%
P/E RatioN/AN/A-
Revenue01.2M-
Total Cash51.4M10.2M504%
Total Debt141K21.6M1%
TECHNICAL ANALYSIS
Technical Analysis
DRUGRANI
RSI
ODDS (%)
Bearish Trend 2 days ago
75%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
89%
Momentum
ODDS (%)
Bullish Trend 2 days ago
89%
Bearish Trend 2 days ago
89%
MACD
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
84%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
86%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 8 days ago
83%
Declines
ODDS (%)
Bearish Trend 4 days ago
88%
Bearish Trend 4 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
86%
Bullish Trend 2 days ago
70%
Aroon
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
86%
View a ticker or compare two or three
Interact to see
Advertisement
DRUG
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RANI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
OXY46.990.10
+0.21%
Occidental Petroleum Corp
BLFY9.41-0.04
-0.42%
Blue Foundry Bancorp
BANF130.40-0.61
-0.47%
BancFirst Corp
HLF8.75-0.23
-2.56%
Herbalife Ltd
TC13.19-0.51
-3.72%
Token Cat Limited

RANI and

Correlation & Price change

A.I.dvisor indicates that over the last year, RANI has been loosely correlated with XENE. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if RANI jumps, then XENE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RANI
1D Price
Change %
RANI100%
-2.20%
XENE - RANI
36%
Loosely correlated
-0.19%
ADVM - RANI
34%
Loosely correlated
-0.69%
VYGR - RANI
32%
Poorly correlated
-3.76%
VNDA - RANI
32%
Poorly correlated
-1.43%
DRUG - RANI
31%
Poorly correlated
+2.69%
More